Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

by Kari T. Syvänen, Hannu Järveläinen, Pekka Taimen, Matti Laato, Peter J. Boström
Published 2014-05-01

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression.

by Irena Saarinen, Tuomas Mirtti, Heikki Seikkula, Peter J Boström, Pekka Taimen
Published 2015-01-01

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer

by Matias Blomqvist, Ilmari Koskinen, Eliisa Löyttyniemi, Tuomas Mirtti, Peter J. Boström, Pekka Taimen
Published 2021-07-01

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation

by Heikki Seikkula, Peter J. Boström, Karri Seppä, Janne Pitkäniemi, Nea Malila, Antti Kaipia
Published 2020-03-01

Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer

by Minna Tervahartiala, Pekka Taimen, Tuomas Mirtti, Ilmari Koskinen, Thorsten Ecke, Sirpa Jalkanen, Peter J. Boström
Published 2017-10-01

Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies.

by Annele Sainio, Marie Nyman, Riikka Lund, Sanna Vuorikoski, Pia Boström, Matti Laato, Peter J Boström, Hannu Järveläinen
Published 2013-01-01

Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer.

by Minna M Boström, Heikki Irjala, Tuomas Mirtti, Pekka Taimen, Tommi Kauko, Annika Ålgars, Sirpa Jalkanen, Peter J Boström
Published 2015-01-01

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results

by Mikael Anttinen, Pietari Mäkelä, Antti Viitala, Pertti Nurminen, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström
Published 2020-12-01

Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells

by Mikael Anttinen, Eemil Yli-Pietilä, Visa Suomi, Pietari Mäkelä, Teija Sainio, Jani Saunavaara, Lauri Eklund, Roberto Blanco Sequeiros, Pekka Taimen, Peter J. Boström
Published 2019-01-01

11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)

by Antti Salminen, Ivan Jambor, Harri Merisaari, Otto Ettala, Johanna Virtanen, Ilmari Koskinen, Erik Veskimae, Jukka Sairanen, Pekka Taimen, Jukka Kemppainen, Heikki Minn, Peter J. Boström
Published 2018-08-01

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization.

by Jussi Toivonen, Ileana Montoya Perez, Parisa Movahedi, Harri Merisaari, Marko Pesola, Pekka Taimen, Peter J Boström, Jonne Pohjankukka, Aida Kiviniemi, Tapio Pahikkala, Hannu J Aronen, Ivan Jambor
Published 2019-01-01

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.

by Saeid Alinezhad, Riina-Minna Väänänen, Jesse Mattsson, Yifeng Li, Terhi Tallgrén, Natalia Tong Ochoa, Anders Bjartell, Malin Åkerfelt, Pekka Taimen, Peter J Boström, Kim Pettersson, Matthias Nees
Published 2016-01-01

Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.

by Saeid Alinezhad, Riina-Minna Väänänen, Jesse Mattsson, Yifeng Li, Terhi Tallgrén, Natalia Tong Ochoa, Anders Bjartell, Malin Åkerfelt, Pekka Taimen, Peter J Boström, Kim Pettersson, Matthias Nees
Published 2016-01-01

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma

by Kalle E. Mattila, Teemu D. Laajala, Sara V. Tornberg, Tuomas P. Kilpeläinen, Paula Vainio, Otto Ettala, Peter J. Boström, Harry Nisen, Laura L. Elo, Panu M. Jaakkola
Published 2021-04-01

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille...

by Sultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, Bas Van Rhijn, David M Kakiashvili, Neil Fleshner, Michael Jewett, Michel Petein, Claude Schulman, Sally Hanna, Peter J Bostrom, Thierry Roumeguere, Shahrokh F Shariat, Sandrine Rorive, Alexandre R Zlotta
Published 2011-01-01

SORLA regulates endosomal trafficking and oncogenic fitness of HER2

by Mika Pietilä, Pranshu Sahgal, Emilia Peuhu, Niklas Z. Jäntti, Ilkka Paatero, Elisa Närvä, Hussein Al-Akhrass, Johanna Lilja, Maria Georgiadou, Olav M. Andersen, Artur Padzik, Harri Sihto, Heikki Joensuu, Matias Blomqvist, Irena Saarinen, Peter J. Boström, Pekka Taimen, Johanna Ivaska
Published 2019-05-01

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.

by Ivan Jambor, Janne Verho, Otto Ettala, Juha Knaapila, Pekka Taimen, Kari T Syvänen, Aida Kiviniemi, Esa Kähkönen, Ileana Montoya Perez, Marjo Seppänen, Antti Rannikko, Outi Oksanen, Jarno Riikonen, Sanna Mari Vimpeli, Tommi Kauko, Harri Merisaari, Markku Kallajoki, Tuomas Mirtti, Tarja Lamminen, Jani Saunavaara, Hannu J Aronen, Peter J Boström
Published 2019-06-01

Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study

by Patrick Leo, Andrew Janowczyk, Robin Elliott, Nafiseh Janaki, Kaustav Bera, Rakesh Shiradkar, Xavier Farré, Pingfu Fu, Ayah El-Fahmawi, Mohammed Shahait, Jessica Kim, David Lee, Kosj Yamoah, Timothy R. Rebbeck, Francesca Khani, Brian D. Robinson, Lauri Eklund, Ivan Jambor, Harri Merisaari, Otto Ettala, Pekka Taimen, Hannu J. Aronen, Peter J. Boström, Ashutosh Tewari, Cristina Magi-Galluzzi, Eric Klein, Andrei Purysko, Natalie NC Shih, Michael Feldman, Sanjay Gupta, Priti Lal, Anant Madabhushi
Published 2021-05-01